23andMe to slash 40% of its workforce, end therapeutics program to cut costs

SUPREME TEAM

23andMe to slash 40% of its workforce, end therapeutics program to cut costs

delta
November 12, 2024
4:56 am

DNA-testing company 23andMe Holding Co. will slash its workforce by about 40% and discontinue its therapeutics program as part of a restructuring effort to cut costs, the company said Monday…
Read More

23andMe to slash 40% of its workforce, end therapeutics program to cut costs

Leave a Reply Cancel reply

More Article.

Blame the British public for the junior doctors’ strike

The Labour Party is heading for a showdown on Trident

Everything you need to know about Labour’s rolling crisis

Follow & Subscribe to our Newsletter.

Ready to get started, Get our Newsletter and join the Community!